Related Experiment Video
Updated: Jul 6, 2026

DNA Electroporation, Isolation and Imaging of Myofibers
Published on: December 23, 2015
Calpain 3 is a modulator of the dysferlin protein complex in skeletal muscle
Yanchao Huang1, Antoine de Morrée, Alexandra van Remoortere
1Center for Human and Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands.
Abstract:
Muscular dystrophies comprise a genetically heterogeneous group of degenerative muscle disorders characterized by progressive muscle wasting and weakness. Two forms of limb-girdle muscular dystrophy, 2A and 2B, are caused by mutations in calpain 3 (CAPN3) and dysferlin (DYSF), respectively. While CAPN3 may be involved in sarcomere remodeling, DYSF is proposed to play a role in membrane repair. The coexistence of CAPN3 and AHNAK, a protein involved in subsarcolemmal cytoarchitecture and membrane repair, in the dysferlin protein complex and the presence of proteolytic cleavage fragments of AHNAK in skeletal muscle led us to investigate whether AHNAK can act as substrate for CAPN3. We here demonstrate that AHNAK is cleaved by CAPN3 and show that AHNAK is lost in cells expressing active CAPN3. Conversely, AHNAK accumulates when calpain 3 is defective in skeletal muscle of calpainopathy patients. Moreover, we demonstrate that AHNAK fragments cleaved by CAPN3 have lost their affinity for dysferlin. Thus, our findings suggest interconnectivity between both diseases by revealing a novel physiological role for CAPN3 in regulating the dysferlin protein complex.
Insights
Calpain 3 (CAPN3) cleaves AHNAK, a protein crucial for membrane repair. This study reveals CAPN3
Area of Science:
- Molecular Biology
- Muscle Physiology
- Genetics
Background:
- Muscular dystrophies are progressive muscle disorders.
- Limb-girdle muscular dystrophy types 2A and 2B are linked to mutations in calpain 3 (CAPN3) and dysferlin (DYSF), respectively.
- CAPN3 is implicated in sarcomere remodeling, while DYSF is involved in membrane repair.
Purpose of the Study:
- To investigate if AHNAK, a protein in the dysferlin complex, is a substrate for CAPN3.
- To explore the functional relationship between CAPN3 and AHNAK in muscle health.
Main Methods:
- In vitro cleavage assays to test AHNAK as a CAPN3 substrate.
- Analysis of AHNAK levels in cells expressing active CAPN3.
- Examination of AHNAK accumulation in skeletal muscle of calpainopathy patients.
- Assessment of AHNAK fragment binding to dysferlin.
Main Results:
- AHNAK is demonstrated to be cleaved by CAPN3.
- AHNAK is degraded in cells with active CAPN3 and accumulates when CAPN3 is defective.
- CAPN3-cleaved AHNAK fragments exhibit reduced affinity for dysferlin.
Conclusions:
- Calpain 3 (CAPN3) has a novel physiological role in regulating the dysferlin protein complex through AHNAK cleavage.
- Findings suggest an interconnectivity between muscular dystrophies caused by CAPN3 and DYSF mutations.
Related Concept Videos
The Sarcomere
Each myosin...
Actin Filament Depolymerization
In F-actin, the ADF/cofilin proteins...
Cross-bridge Cycle
Calmodulin-dependent Signaling
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cytoskeletal Accessory Proteins

